Edwards Lifesciences CorporationEWNYSE
Loading
EV to Sales HistoryFair Value
Percentile Rank57
3Y CAGR-2.9%
5Y CAGR-9.4%
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-2.9%/yr
vs -0.0%/yr prior
5Y CAGR
-9.4%/yr
Recent acceleration
Acceleration
-2.8pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthFair Value
PeriodValueYoY Change
20257.85+1.9%
20247.70-15.8%
20239.14+6.8%
20228.57-44.4%
202115.40+19.9%
202012.84+16.1%
201911.06+29.0%
20188.57+22.8%
20176.98+4.3%
20166.70-